Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548795 · ClinicalTrials.gov registry record
Viral-Related Neutrophil Response and Condition Severity in People With ARDS
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 132
- Enrollment target
NCT00548795: Completed study, sponsored by National Jewish Health.
NCT00548795 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00548795 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
Acute respiratory distress syndrome (ARDS) is a severe lung condition that can result from a bacterial infection in the lungs. Viral infections may impair the body's immune system response to bacteria, which may lead to more serious lung injury. This study will evaluate the association between the immune response and ARDS severity in people who have ARDS plus a viral infection.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-07 |
What the finished NCT00548795 record still lists
NCT00548795 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00548795 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00548795 about?
NCT00548795 is a clinical study titled "Viral-Related Neutrophil Response and Condition Severity in People With ARDS". Acute respiratory distress syndrome (ARDS) is a severe lung condition that can result from a bacterial infection in the lungs. Viral infections may impair the body's immune system response to bacteria, which may lead to more serious lung injury. This study will evaluate the association between the i...
What is the current status of trial NCT00548795?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2007-08. Estimated completion is 2012-07.
Who is sponsoring clinical trial NCT00548795?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia